NMRA vs. AVGO

Last updated Apr 2, 2026

Compare and contrast key facts about Neumora Therapeutics Inc. Common Stock (NMRA) and Broadcom Inc. (AVGO).

Performance

NMRA vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neumora Therapeutics Inc. Common Stock (NMRA) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

NMRA vs. AVGO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
NMRA Neumora Therapeutics Inc. Common Stock	16.76%	-83.11%	-37.83%	0.29%
AVGO Broadcom Inc.	-9.23%	50.63%	110.49%	29.35%

Fundamentals

Market Cap NMRA : $341.49M AVGO : $1.53T
EPS NMRA : -$1.46 AVGO : $5.13
PB Ratio NMRA : 3.29 AVGO : 19.18
Total Revenue (TTM) NMRA : $0.00 AVGO : $68.28B
Gross Profit (TTM) NMRA : -$5.00M AVGO : $46.31B
EBITDA (TTM) NMRA : -$241.16M AVGO : $36.65B

Returns By Period

In the year-to-date period, NMRA achieves a 16.76% return, which is significantly higher than AVGO's -9.23% return.

NMRA

• 1D: 7.18%
• 1M: -34.69%
• YTD: 16.76%
• 6M: 17.42%
• 1Y: 128.84%
• 3Y*: —
• 5Y*: —
• 10Y*: —

AVGO

• 1D: 1.29%
• 1M: -1.47%
• YTD: -9.23%
• 6M: -5.59%
• 1Y: 87.53%
• 3Y*: 71.96%
• 5Y*: 48.74%
• 10Y*: 38.30%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NMRA vs. AVGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NMRA

NMRA Risk / Return Rank: 78
NMRA Sharpe Ratio Rank: 78
NMRA Sortino Ratio Rank: 83
NMRA Omega Ratio Rank: 78
NMRA Calmar Ratio Rank: 79
NMRA Martin Ratio Rank: 72

AVGO

AVGO Risk / Return Rank: 86
AVGO Sharpe Ratio Rank: 88
AVGO Sortino Ratio Rank: 86
AVGO Omega Ratio Rank: 84
AVGO Calmar Ratio Rank: 86
AVGO Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NMRA vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neumora Therapeutics Inc. Common Stock (NMRA) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NMRA	AVGO	Difference
Sharpe ratio Return per unit of total volatility	1.23	1.82	-0.60
Sortino ratio Return per unit of downside risk	2.39	2.55	-0.15
Omega ratio Gain probability vs. loss probability	1.27	1.33	-0.06
Calmar ratio Return relative to maximum drawdown	2.36	3.10	-0.74
Martin ratio Return relative to average drawdown	4.31	7.61	-3.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NMRA vs. AVGO - Sharpe Ratio Comparison

The current NMRA Sharpe Ratio is 1.23, which is lower than the AVGO Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of NMRA and AVGO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NMRA	AVGO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.23	1.82	-0.60
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.16	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.99	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.54	1.06	-1.60

Correlation

The correlation between NMRA and AVGO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NMRA vs. AVGO - Dividend Comparison

NMRA has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.79%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NMRA Neumora Therapeutics Inc. Common Stock	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
AVGO Broadcom Inc.	0.79%	0.70%	0.94%	1.71%	3.02%	2.24%	3.05%	3.54%	3.11%	1.87%	1.43%	1.13%

Drawdowns

NMRA vs. AVGO - Drawdown Comparison

The maximum NMRA drawdown since its inception was -96.89%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for NMRA and AVGO.

Drawdown Indicators

	NMRA	AVGO	Difference
Max Drawdown Largest peak-to-trough decline	-96.89%	-48.30%	-48.59%
Max Drawdown (1Y) Largest decline over 1 year	-46.24%	-28.67%	-17.57%
Max Drawdown (5Y) Largest decline over 5 years	—	-41.15%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-48.30%	—
Current Drawdown Current decline from peak	-89.42%	-23.78%	-65.64%
Average Drawdown Average peak-to-trough decline	-61.85%	-8.00%	-53.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.30%	11.66%	+13.64%

Volatility

NMRA vs. AVGO - Volatility Comparison

Neumora Therapeutics Inc. Common Stock (NMRA) has a higher volatility of 25.03% compared to Broadcom Inc. (AVGO) at 12.62%. This indicates that NMRA's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NMRA	AVGO	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.03%	12.62%	+12.41%
Volatility (6M) Calculated over the trailing 6-month period	70.10%	32.50%	+37.60%
Volatility (1Y) Calculated over the trailing 1-year period	106.09%	48.25%	+57.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	103.54%	42.33%	+61.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	103.54%	38.90%	+64.64%

Financials